Key Insights

Highlights

Treatment Research

4 treatments under study, led by Petiveria Alliacea Preparation

Research Leaders

5 sponsors active, led by Jian-Kun Hu

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Phase 1 (1)
Phase 1/2 (1)

Trial Status

Unknown3
Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT06033976RecruitingPrimary

Endoscopic Submucosal Dissection Registry

NCT05587088Phase 1/2UnknownPrimary

Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)

NCT03563326Phase 1UnknownPrimary

Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)

NCT03597672UnknownPrimary

Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)

Showing all 4 trials

Research Network

Common Treatments

  • Petiveria Alliacea Preparation1
  • Cart Cells Targeting Epcam1
  • Endoscopic Submucosal Dissection Esd1
  • Chemotherapy1

Active Sponsors

  • Jian-Kun Hu2
  • Pontificia Universidad Javeriana1
  • Carol Davila University of Medicine and Pharmacy1
  • Hospital Universitario San Ignacio1
  • Xin-Zu Chen1

Top Investigators

Related Conditions

  • Acute Leukemia1
  • Acute Myeloid Leukemia In Relapse1
  • Pancreatic Neoplasms1
  • Metastases Neoplasm1
  • Neoplasm Duodenal1

Activity Timeline